---
document_datetime: 2025-08-20 13:56:31
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/rimmyrah-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: rimmyrah-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.1541045
conversion_datetime: 2025-12-23 04:58:17.011298
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Rimmyrah

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                     | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                           |
|----------------------|-------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|---------------------------------------------------|
| Variation type II /  | B.II.e.1.b Change in type of container or | 10/07/2025                          |                                             | SmPC,                            | The SmPC has been updated as follows: addition of |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000246182   | addition of a new container - B.II.e.1.b.2 Sterile medicinal products and biological/ immunological medicinal products - Accepted   | Labelling and PL   | a new presentation 'Rimmyrah 10 mg/ml solution for injection in pre-filled syringe'. The Labelling and PL have been updated accordingly.   |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------|